The 1950s and ‘60s poisoning event was long attributed to methylmercury, but studies at SLAC suggest a different compound was to blame. The findings could reshape toxicologists’ understanding of disease related to mercury poisoning.

What they learned could lead to a better understanding of how antibiotics are broken down in the body, potentially leading to the development of more effective drugs.

A new study uncovers how a critical protein binds to drugs used to treat asthma and other inflammatory diseases.

A better understanding of ‘checkpoint proteins,’ which protect cancer cells against immune system strikes, could lead to the development of more effective drugs.

After meeting at a party, a Stanford psychologist and SLAC particle physicists have collaborated on a new kind of EEG device that can stimulate the brain and read out the effects.

A new study shows how soccer ball-shaped molecules burst more slowly than expected when blasted with an X-ray laser beam.

Stanford virologists are working with scientists at the new Stanford-SLAC Cryo-Electron Microscopy facility to take a new look at how herpesviruses infect cells.

A better understanding of how these receptors work could enable scientists to design better therapeutics for sleep disorders, cancer and Type 2 diabetes.

In the decade since LCLS produced its first light, it has pushed boundaries in countless areas of discovery.

New research will help in the quest to design low-cost drugs that can tackle postpartum bleeding and other conditions without severe side effects.

SLAC and Stanford researchers secure support for two projects that share one goal: to reduce the side effects of radiation therapy by vastly shrinking the length of a typical session.

In a first, researchers measure extremely small and fast changes that occur in plasma when it’s zapped with a laser. Their technique will have applications in astrophysics, medicine and fusion energy.